News | Radiation Therapy | August 02, 2019

Varian Showcases Cancer Care Systems and Software at AAPM 2019

Offerings highlighted by Identify guidance system for enhanced patient identification, positioning and motion management during surface-guided radiation therapy

Varian Showcases Cancer Care Systems and Software at AAPM 2019

August 2, 2019 — Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the recent American Association of Physicists in Medicine (AAPM) 2019 annual meeting, July 14-18  in San Antonio, Texas.

Identify is an automated patient identification, positioning and motion management system for radiation therapy. It incorporates patient safety, quality, efficiency and surface-guidance features in an automated workflow solution for surface-guided radiation therapy (SGRT). 

Other Varian solutions showcased bring together artificial intelligence (AI), data analytics, science and technology, and include:

  • RapidPlan leverages machine learning to help clinicians achieve greater treatment plan consistency, efficiency and quality;
  • Multi-Criteria Optimization (MCO) improves the efficiency and quality of treatment planning by helping clinicians explore clinical tradeoffs when they vary plan parameters;
  • Noona is an intuitive solution for patients to report on their symptoms and outcomes, enabling better symptom monitoring, proactive management, and patient triage; and
  • ProBeam 360° system, designed for next-generation proton therapy, offers high-level clinical capabilities, a 360-degree gantry and RapidScan technology, which simplifies the process of motion management by delivering each field in a single breath-hold

Also on display was the full spectrum of Varian software solutions for: brachytherapy treatment planning and guidance, practice management, radiosurgery delivery, machine quality assurance, imaging informatics, image-guided dosimetry for Y90 selective internal radiation therapy (SIRT), tumor board management and more.

For more information: www.varian.com

Related Content

News | Radiation Therapy | May 06, 2021
May 6, 2021 — Individuals living with severe...
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
The emergence of #therapeutic #radiopharmaceuticals and its adoption in #cancer care provide one more weapon in combating cancer

Getty Images

Feature | Radiation Oncology | May 04, 2021 | By Vinay Shivaprasad
The term nuclear medicine is associated with the diag
Despite receiving high radiation doses to their tumors, lung cancer patients treated with technique that spares a large part of the esophagus did not develop severe inflammation of the esophagus

Getty Images

News | Lung Imaging | April 30, 2021
April 30, 2021 — For many patients with localized lung cance...
#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate canc
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
A phase 1 clinical trial led by investigators at the University of Chicago Medicine testing the effects of stereotactic body radiotherapy for treating multiple metastases has determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases.

Image courtesy of Accuray

News | Stereotactic Body Radiation Therapy (SBRT) | April 23, 2021
April 23, 2021 — A phase 1 clinical trial led by investigators at the...